Rely on the Neurological Expertise of Worldwide Clinical Trials for Your Groundbreaking Research in Dementia with Lewy Bodies

Dementia with Lewy Bodies (DLB) is a neurodegenerative disorder whose symptoms include cognitive impairment and involuntary physical movements. Because of its commonalities with other neurological conditions, such as Parkinson’s disease and Alzheimer’s disease, individuals with DLB are often misdiagnosed initially. Few studies have been conducted on DLB, and there is ample opportunity for advancing knowledge and treatment therapies for this indication. Identifying suitable patients for DLB studies is a challenge because of the difficulties in accurately diagnosing the condition.

With 30+ years in the field of Alzheimer’s and other dementia-related research, Worldwide Clinical Trials has the necessary experience and the acute understanding of the specificities of various neurological conditions to take on an investigation of Lewy body dementia. Our therapeutically focused team brings to your study the necessary attention to protocol design and patient enrollment criteria. Our global network of highly trained clinical sites ensure that data is collected with investigational acuity and regulatory adherence.